397 related articles for article (PubMed ID: 22136662)
1. A European multicentre reappraisal of distal compound muscle action potential duration in chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Lagarde J; Cassereau J; Viala K; Fournier E; Nicolas G
Eur J Neurol; 2012 Apr; 19(4):638-42. PubMed ID: 22136662
[TBL] [Abstract][Full Text] [Related]
2. Effects of low frequency filtering on distal compound muscle action potential duration for diagnosis of CIDP: A Japanese-European multicenter prospective study.
Mitsuma S; Van den Bergh P; Rajabally YA; Van Parijs V; Martin-Lamb D; Sonoo M; Inaba A; Shimizu T; Isose S; Sato Y; Komori T; Misawa S; Kuwabara S;
Clin Neurophysiol; 2015 Sep; 126(9):1805-10. PubMed ID: 25591830
[TBL] [Abstract][Full Text] [Related]
3. Is total duration of distal compound muscle action potential better than negative peak duration in the diagnosis of chronic inflammatory demyelinating polyneuropathy?
Lagarde J; Viala K; Fournier E
Muscle Nerve; 2014 Jun; 49(6):895-9. PubMed ID: 24114712
[TBL] [Abstract][Full Text] [Related]
4. Duration of the distal compound muscle action potential for diagnosis of chronic inflammatory demyelinating polyneuropathy: effects of low-cut filters.
Isose S; Misawa S; Sonoo M; Shimuzu T; Oishi C; Shibuya K; Nasu S; Sekiguchi Y; Mitsuma S; Beppu M; Omori S; Komori T; Kokubun N; Inaba A; Hirashima F; Kuwabara S;
J Clin Neurophysiol; 2014 Oct; 31(5):441-3. PubMed ID: 25271683
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiological sensory demyelination in typical chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Samarasekera S
Eur J Neurol; 2010 Jul; 17(7):939-44. PubMed ID: 20158514
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiological features of POEMS syndrome and chronic inflammatory demyelinating polyneuropathy.
Guo X; Qin X; Zhang Y; Huang C; Yu G
J Clin Neurosci; 2014 Apr; 21(4):587-90. PubMed ID: 24268501
[TBL] [Abstract][Full Text] [Related]
7. Value of distal compound muscle action potential duration prolongation in acute inflammatory demyelinating polyneuropathy: a European perspective.
Rajabally YA; Nicolas G
Muscle Nerve; 2011 May; 43(5):751-5. PubMed ID: 21404299
[TBL] [Abstract][Full Text] [Related]
8. Proximal nerve conduction studies in chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Jacob S
Clin Neurophysiol; 2006 Sep; 117(9):2079-84. PubMed ID: 16859987
[TBL] [Abstract][Full Text] [Related]
9. Length-dependent weakness and electrophysiological signs of secondary axonal loss in chronic inflammatory demyelinating polyradiculoneuropathy.
Harbo T; Andersen H; Jakobsen J
Muscle Nerve; 2008 Aug; 38(2):1036-45. PubMed ID: 18642356
[TBL] [Abstract][Full Text] [Related]
10. Utility of the distal compound muscle action potential duration for diagnosis of demyelinating neuropathies.
Isose S; Kuwabara S; Kokubun N; Sato Y; Mori M; Shibuya K; Sekiguchi Y; Nasu S; Fujimaki Y; Noto Y; Sawai S; Kanai K; Hirata K; Misawa S;
J Peripher Nerv Syst; 2009 Sep; 14(3):151-8. PubMed ID: 19909478
[TBL] [Abstract][Full Text] [Related]
11. Segmental evaluation of the peripheral nerve using tibial nerve SEPs for the diagnosis of CIDP.
Tsukamoto H; Sonoo M; Shimizu T
Clin Neurophysiol; 2010 Jan; 121(1):77-84. PubMed ID: 19850515
[TBL] [Abstract][Full Text] [Related]
12. Electrophysiological demyelinating features in hereditary ATTR amyloidosis.
Ohashi N; Kodaira M; Morita H; Sekijima Y
Amyloid; 2019 Mar; 26(1):15-23. PubMed ID: 30688105
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity and specificity of electrodiagnostic criteria for CIDP using ROC curves: comparison to patients with diabetic and MGUS associated neuropathies.
Wilson J; Chawla J; Fisher M
J Neurol Sci; 2005 Apr; 231(1-2):19-28. PubMed ID: 15792816
[TBL] [Abstract][Full Text] [Related]
14. Transthyretin amyloid polyneuropathies mimicking a demyelinating polyneuropathy.
Lozeron P; Mariani LL; Dodet P; Beaudonnet G; Théaudin M; Adam C; Arnulf B; Adams D
Neurology; 2018 Jul; 91(2):e143-e152. PubMed ID: 29907605
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 2-limb versus 3-limb electrodiagnostic studies in the evaluation of chronic inflammatory demyelinating polyneuropathy.
Vo ML; Hanineva A; Chin RL; Carey BT; Latov N; Langsdorf JA
Muscle Nerve; 2015 Apr; 51(4):549-53. PubMed ID: 25131219
[TBL] [Abstract][Full Text] [Related]
16. Validity of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy: a multicentre European study.
Rajabally YA; Nicolas G; Piéret F; Bouche P; Van den Bergh PY
J Neurol Neurosurg Psychiatry; 2009 Dec; 80(12):1364-8. PubMed ID: 19622522
[TBL] [Abstract][Full Text] [Related]
17. Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy.
Thaisetthawatkul P; Logigian EL; Herrmann DN
Neurology; 2002 Nov; 59(10):1526-32. PubMed ID: 12451191
[TBL] [Abstract][Full Text] [Related]
18. Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP.
Mauermann ML; Sorenson EJ; Dispenzieri A; Mandrekar J; Suarez GA; Dyck PJ; Dyck PJ
J Neurol Neurosurg Psychiatry; 2012 May; 83(5):480-6. PubMed ID: 22396441
[TBL] [Abstract][Full Text] [Related]
19. Practical electrodiagnostic value of F-wave studies in chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Varanasi S
Clin Neurophysiol; 2013 Jan; 124(1):171-5. PubMed ID: 22748564
[TBL] [Abstract][Full Text] [Related]
20. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy.
Kuwabara S; Isose S; Mori M; Mitsuma S; Sawai S; Beppu M; Sekiguchi Y; Misawa S
J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1054-9. PubMed ID: 25424435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
